Showing 98 of 98on this page. Filters & sort apply to loaded results; URL updates for sharing.98 of 98 on this page
Coherus Solutions - Working together to ensure patient success
Coherus Announces FDA Approval of UDENYCA ONBODY™, a Novel and ...
Coherus Logo Georgia Erbez Appointed As Board Director And Audit
Coherus Announces Clinical Collaboration with the Cancer Research ...
Coherus BioSciences Initiates Phase 2 Study of Casdozokitug Combined ...
CHRS | Coherus BioSciences, Inc. Stock Data, Price & News
Coherus Oncology (NASDAQ:CHRS) Stock Price Crosses Above Two Hundred ...
Coherus BioSciences on LinkedIn: #jefferieshealthcare
Coherus BioSciences on LinkedIn: #biosimilars
Mark Cuban Cost Plus Drug company joins forces with Coherus - available ...
Coherus | Immuno-Oncology and Biosimilar Therapies
Coherus will report Q4 and Full Year 2024 financial results on March 10 ...
Coherus Completes Strategic Transformation to Coherus Oncology ...
Coherus Completes Transformation to Focus Exclusively on Cancer ...
Coherus BioSciences reducirá su plantilla un 30% tras la venta de su ...
Coherus BioSciences sells Udenyca franchise to Intas Pharmaceuticals ...
Coherus Rep Discusses Interchangeable Ophthalmology Biosimilar ...
Coherus Oncology | Innovative Cancer Medicines | Portfolio
Coherus Biosciences' Outsourcing Strategy
Patient Advocacy - Coherus BioSciences
Coherus Oncology | Novel Combination Therapies for Cancer
Coherus Transforms to Focus Solely on Cancer Therapeutics
Coherus Oncology - 22 Fillmore
Coherus BioSciences Forms Golden Cross, Signaling Bullish Breakout Ahead
LTS Launches Sorrel Wearable Drug Delivery Platform with Coherus ...
Coherus Oncology | Novel Therapies for Cancer | Contact
Coherus - Spirolab®
Coherus BioSciences, Inc. (CHRS) Stock Price, News, Quote & History ...
17.01.10 coherus jp morgan final | PPT
Coherus BioSciences (CHRS) Investor Presentation - Slideshow (NASDAQ ...
Coherus Oncology Showcases CHS-114 Breakthrough at SITC 2025 ...
Coherus Sells UDENYCA® Franchise to Intas Pharmaceuticals in $558 ...
Congratulations Coherus BioSciences . Coherus has agreed to sell its ...
Coherus is proud to support Head and Neck Cancer Alliance in their ...
Coherus BioSciences (NASDAQ:CHRS) Stock Falls on FDA Delay - TipRanks.com
Coherus Oncology | Combination Therapies for Cancer | About
Fame | Coherus BioSciences net worth and salary income estimation Apr ...
Coherus BioSciences on LinkedIn: #iosummit
Coherus BioSciences Inc (CHRS) Reports Growth in Net Revenue for Q4 and ...
Coherus BioSciences | Novel Immunotherapies for Cancer
Coherus Oncology Surges 30% Following Oppenheimer’s Outperform Rating
Coherus BioSciences CEO and Key Executive Team | Craft.co
Coherus BioSciences on LinkedIn: #news #biosimilar #inflammatory
Coherus 2020 Transforming Care Delivery with the Oncology Care Model ...
PESTLE Analysis of Coherus Biosciences – MatrixBCG.com
INVESTOR NEWS || Surface Oncology to Merge with Coherus Bioscience ...
Coherus BioSciences on LinkedIn: Hope to see you at the Barclays ...
#esmoimmuno23 #nsclc | Coherus Oncology
Coherus BioSciences: CHS-114 Comes Into View At ASCO, Drug Launches ...
Paul Reider on LinkedIn: The Coherus / Cimerli team is at ASRS this ...
Coherus Biosciences Employee Perks & Benefits | Levels.fyi
Coherus Biosciences Stock Down 21 75% Here's why - YouTube
Coherus BioSciences on LinkedIn: #cancer
Coherus Oncology Stock Surges Following Analyst Ratings and Clinical ...
Coherus to Launch CIMERLI™ (ranibizumab-eqrn) in the United
Jami Taylor Appointed Head of Investor Relations of Coherus BioSciences ...
Coherus Oncology | Novel Cancer Therapies | Job Openings
Coherus BioSciences Is a Biotech Stock to Watch Amidst Partnerships and ...
Coherus BioSciences to launch Lucentis biosimilar | Drug Store News
How Udenyca works
LOQTORZI® (toripalimab-tpzi)
Silo Human Capital
Effective Presentation Design Highlighting Coherus' Oncology ...
Join us in celebrating the launch of our new brand identity and ...
Slide 4
Retina 2023 Presenting Companies | Ophthalmology Innovation Source
Dawn of a New Era for Coherus: Stock Surge Amid Strategic Moves
FDA Approves Coherus' Version of Abbvie's Humira, Best-Selling Drug in ...
On-Body Injector Now Available for Use With Pegfilgrastim Biosimilar ...
California Life Sciences announced 19th annual Pantheon Award Winners ...
Slide 27
Coherus: Cleaning The Balance Sheet And Developing New Drugs (NASDAQ ...
Members - Biosimilars Forum
Barings is pleased to provide a $75 million combined term loan and ...
FDA approves Coherus’ Cimerli for DME, with year-long ...
1.7亿美元预付！Sandoz获得Coherus一款眼科单抗类似药特许经营权 - 知乎
SIRO Digital Agency - WP Engine
FLASCO / Advances in the Treatment of Recurrent Locally Advanced ...
Biotech Bay | BioSpace
Autoinjector Presentation of Pegfilgrastim Biosimilar Udenyca Now Available
Coherus: Biosimilar Specialist With Approval Shot For Cancer Drug ...
